- Investing Ideas
- Belgian Pharmaceuticals & Biotech Healthy high growth potential
Belgian Pharmaceuticals & Biotech Healthy high growth potential
Results
2
0 new
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
2 companies
Hyloris Pharmaceuticals
Market Cap: €126.3m
Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.
HYL
€4.51
7D
-1.1%
1Y
-30.4%
argenx
Market Cap: €45.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€730.20
7D
-4.3%
1Y
31.9%